HoxB7 (747C4a) Antibody sc-81292 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemHoxB7 (747C4a) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $333.00Supplier Page View Company Product Page
Catalog Numbersc-81292
Antibody TypePrimary Antibodies
NCBI Gene AliasesHHO.C1, Hox-2.3, HOX2C, HOX2
Clone747C4a
Quantity100 µg/ml
ApplicationsWB, IP
Reactivityhuman
Conjugate/TagUnconjugated
FormatPurified
ClonalityMonoclonal
Hostmouse
NCBI Full Gene Namehomeobox B7
TargetHoxB7
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Inhibition of HOX/PBX Dimers as a Potential Therapeutic Strategy in Breast Cancer Subtypes Including Triple Negative Breast CancerCurr Issues Mol BiolAugust 7, 2026Richard Morgan, Guy Simpson, Einthavy Arunachalam, Hardev Pandha(Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-17146, 1:1000), anti-HOXB7 (Santa Cruz Biotechnology, sc-81292, 1:1000) anti-HOXC4 (Santa Cruz Biotechnology, sc-398460, 1:1000) and anti-HOXC9 (Santa Cruz Biotechnology,

(2) An induced pluripotent stem cell model of Schwann cell differentiation reveals NF2- related gene regulatory networksResearchSquareJune 16, 2025Olivia Lazaro, Sihong Li, William Carter, Jake Smiley, Oluwamayowa Awosika, Sylvia Robertson, Angela Haskell, Raven Hinkel, Brooke E. Hickey, Steven P. Angus, et al.S100β (Abcam #AB52642), 1:50 dilution of p75 (Abcam #AB3125), 1:100 dilution of HOXb7 (Santa Cruz #sc-81292), and 1:500 dilution of GAP43 (Abcam #AB12274) for SCPs and SCs staining at 4°C overnight, then with

(3) Propofol prevents the aggressive progression of oral squamous cell carcinoma via regulating circ_0005623/miR-195-5p/HOXB7 axisBiotechnology and applied biochemistryJune 1, 2022Cao C, Zhang X, Xu Y.

(4) The let-7c/HoxB7 axis regulates the cell proliferation, migration and apoptosis in hepatocellular carcinomaAnti-cancer drugsJanuary 1, 2020Cai L, Wang Z, Zheng H, Xu L.

(5) HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinomaOncotargetJuly 18, 2017Wang WM, Xu Y, Wang YH, Sun HX, Sun YF, He YF, Zhu QF, Hu B, Zhang X, Xia JL, et al.

(6) In Vitro Generation of Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature from Murine Induced Pluripotent Stem CellsStem cell reportsApril 11, 2017Steens J, Zuk M, Benchellal M, Bornemann L, Teichweyde N, Hess J, Unger K, Görgens A, Klump H, Klein D.

(7) The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathwayProceedings of the National Academy of Sciences of the United States of AmericaFebruary 21, 2012Jin K, Kong X, Shah T, Penet MF, Wildes F, Sgroi DC, Ma XJ, Huang Y, Kallioniemi A, Landberg G, et al.

(8) HOXB7 mediates cisplatin resistance in esophageal squamous cell carcinoma through involvement of DNA damage repairThoracic cancerJanuary 1, 0001"Zhou T, Fu H, Dong B, Dai L, Yang Y, Yan W, Shen L."

Be the First to Write a Review!

HoxB7 (747C4a) Antibody

HoxB7 (747C4a) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (8)

Reviews

HoxB7 (747C4a) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map